Your browser doesn't support javascript.
loading
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data.
Pilz, Stefan; Trummer, Christian; Verheyen, Nicolas; Schwetz, Verena; Pandis, Marlene; Aberer, Felix; Grübler, Martin R; Meinitzer, Andreas; Bachmann, Antonia; Voelkl, Jakob; Alesutan, Ioana; Catena, Cristiana; Sechi, Leonardo A; März, Winfried; Obermayer-Pietsch, Barbara; Tomaschitz, Andreas.
Afiliação
  • Pilz S; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • Trummer C; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • Verheyen N; Department of Cardiology, Medical University of Graz, Graz, Austria.
  • Schwetz V; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • Pandis M; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • Aberer F; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • Grübler MR; Swiss Cardiovascular Center Bern, Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Meinitzer A; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Bachmann A; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • Voelkl J; Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Berlin, Germany.
  • Alesutan I; Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Berlin, Germany.
  • Catena C; Hypertension Unit, Internal Medicine, Department of Experimental and Clinical Medical Sciences, University of Udine, Udine, Italy.
  • Sechi LA; Hypertension Unit, Internal Medicine, Department of Experimental and Clinical Medical Sciences, University of Udine, Udine, Italy.
  • März W; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Obermayer-Pietsch B; Synlab Academy, Synlab Services GmbH, Mannheim, Germany.
  • Tomaschitz A; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
Horm Metab Res ; 50(5): 375-382, 2018 May.
Article em En | MEDLINE | ID: mdl-29723896
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espironolactona / Renina / Aldosterona / Antagonistas de Receptores de Mineralocorticoides / Hiperaldosteronismo / Hiperparatireoidismo Tipo de estudo: Clinical_trials / Guideline / Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Horm Metab Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espironolactona / Renina / Aldosterona / Antagonistas de Receptores de Mineralocorticoides / Hiperaldosteronismo / Hiperparatireoidismo Tipo de estudo: Clinical_trials / Guideline / Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Horm Metab Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Áustria